Does Kaletra Solution Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SELECTED PROTEASE INHIBITORS/BEPRIDIL
- PROTEASE INHIBITORS/ORAL MIDAZOLAM; TRIAZOLAM
- RITONAVIR/PROPOXYPHENE
- SELECTED CYP3A4 INHIBITORS/PIMOZIDE
- PROTEASE INHIBITORS/ERGOT ALKALOIDS
- SELECTED CYP3A4 SUBSTRATES/RIFAMPIN
- PROTEASE INHIBITORS; COBICISTAT/ASTEMIZOLE; TERFENADINE
- SELECTED CYP3A4 SUBSTRATES/ST. JOHN'S WORT
- PROTEASE INHIBITORS/APALUTAMIDE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/GEPIRONE
- SELECTED STRONG AND MODERATE CYP3A4 INHIBITORS/CISAPRIDE
- STR 3A4 INHIB;ATAZAN;DARUN/COLCHICINE (FOR CARDIOPROTECTION)
- STRONG CYP3A4 INHIBIT THAT PROLONG QT/PIMAVANSERIN (> 10 MG)
- STRONG CYP3A4 INHIBITORS/MAVACAMTEN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/PACRITINIB
- STR CYP3A4 INHIBITORS THAT PROLONG QT/PANOBINOSTAT (> 10 MG)
- STRONG CYP3A4 INHIBITORS/DARIDOREXANT
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/LEVOKETOCONAZOLE
- SELECTED STRONG CYP3A4 INHIBITORS/CONIVAPTAN
- STRONG CYP3A4 INHIBITORS/FINERENONE
- STRONG CYP3A4 INHIBITORS/VOCLOSPORIN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/RANOLAZINE
- UGT1A1 INDUCERS/CABOTEGRAVIR
- CYP3A4 & UGT1A1 INDUCERS/CABOTEGRAVIR-RILPIVIRINE
- STRONG AND MODERATE CYP3A4 INHIBITORS/LONAFARNIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/IVABRADINE
- STRONG CYP3A4 INHIB; PROTEASE INHIB/LUMATEPERONE (>10.5 MG)
- STRONG CYP3A4 INHIBITORS/UBROGEPANT
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR;DARUNAVIR/LERCANIDIPINE
- RITONAVIR/NERATINIB
- SLT STRONG & MODERATE CYP3A4 INHIBITORS/CILOSTAZOL (>50MG)
- STRONG CYP3A4 INHIBITORS/DAPAGLIFLOZIN-SAXAGLIPTIN-METFORMIN
- STRONG AND MODERATE CYP3A4 INHIBITORS/ASUNAPREVIR
- STRONG CYP3A4 INHIBITORS/VALBENAZINE (> 40 MG)
- STRONG OR MODERATE CYP3A4 INHIBITORS/LOMITAPIDE
- OATP1B1-3 INHIBITORS/ELBASVIR-GRAZOPREVIR
- STRONG CYP3A4 INHIBITORS/NALOXEGOL
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/AVANAFIL
- 3A4INHIB/DAPOXETINE;LEVOMILNACIPRAN(>80MG);VILAZODONE(>20MG)
- STRONG OR MODERATE CYP3A4 INHIBITORS/FLIBANSERIN
- STRONG CYP3A4 INHIBITORS/SLT HIGH STRENGTH ANTIMUSCARINICS
- SELECTED STRONG AND MODERATE CYP3A4 INHIBITORS/DOMPERIDONE
- SELECTED PROTEASE INHIBITORS/ATORVASTATIN (>20 MG)
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/TICAGRELOR
- PROTEASE INHIBITORS; COBICISTAT/LURASIDONE
- HIV PROTEASE INHIBITORS; COBICISTAT/SILDENAFIL (FOR PAH)
- STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/SAXAGLIPTIN (>2.5 MG)
- STRONG CYP3A4 INHIBITORS; DARUNAVIR/DRONEDARONE
- ATAZANAVIR; LOPINAVIR; SIMEPREVIR/ROSUVASTATIN (> 10 MG)
- HIV PROTEASE INHIBITORS; COBICISTAT/RIVAROXABAN
- STRONG CYP3A4 INHIBITORS/TOLVAPTAN
- PROTEASE INHIBITORS/ALFUZOSIN;SILODOSIN;TAMSULOSIN
- SELECTED PROTEASE INHIBITORS/VARDENAFIL (> 2.5 MG)
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/EPLERENONE
- STRONG CYP3A4 INHIBITORS/IRINOTECAN
- SELECTED PROTEASE INHIBITORS; COBICISTAT/ELETRIPTAN
- SELECTED CYP3A4 INHIBITORS/LOVASTATIN; SIMVASTATIN
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- RITONAVIR/MEPERIDINE
- SELECTED PROTEASE INHIBITORS/ALPRAZOLAM
- SELECTED PROTEASE INHIBITORS/CONTRACEPTIVES
- SELECTED PROTEASE INHIBITORS/RIFABUTIN; RIFAPENTINE
- PROTEASE INHIBITORS/CARBAMAZEPINE
- SELECTED PROTEASE INHIBITORS AND NNRTIS/GARLIC
- LOPINAVIR/TIPRANAVIR
- LOPINAVIR/QT PROLONGING AGENTS
- RITONAVIR & RITONAVIR-BOOSTED PROTEASE INHIBITORS/BOCEPREVIR
- PROTEASE INHIBITORS/ENZALUTAMIDE
- SEL SENSITIVE 3A4 SUBSTRATES THAT PROLONG QT/ADAGRASIB
- ANTI-RETROVIRALS/ATIDARSAGENE AUTOTEMCEL
- ANTI-RETROVIRALS/LOVOTIBEGLOGENE AUTOTEMCEL
- STRONG AND MODERATE CYP3A4 INHIBITORS/NIROGACESTAT
- STRONG CYP3A4 INHIBITORS/CAPIVASERTIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/REPOTRECTINIB
- STRONG CYP3A4 OR MODERATE CYP2C9 INHIBITORS/ERDAFITINIB
- STRONG CYP3A4 INHIBITORS/REBOXETINE
- SELECTED CYP3A4 INHIBITORS/MEPERIDINE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/QUIZARTINIB
- STRONG CYP3A4 INHIBITORS/PALOVAROTENE
- STRONG CYP3A4 INHIBITORS/TRETINOIN
- STRONG CYP3A4 INHIBITORS/LENIOLISIB
- OATP1B3 INHIBITORS/ZAVEGEPANT
- STRONG CYP3A4 INHIBITORS/OMAVELOXOLONE
- STRONG CYP3A4 INHIBITORS/SPARSENTAN
- HIV PROTEASE INHIBITORS; COBICISTAT/APIXABAN
- STRONG AND MODERATE CYP3A4 INHIBITORS/ELACESTRANT
- STRONG CYP3A4 INHIBITORS/PIRTOBRUTINIB
- SELECT PROTEASE INHIBITORS; COBICISTAT/TADALAFIL (BPH)
- STRONG CYP3A4 INHIBITORS/PEXIDARTINIB
- DUAL STRONG CYP3A4 & P-GP INHIBITORS/FUTIBATINIB
- ANTI-RETROVIRALS/ELIVALDOGENE AUTOTEMCEL
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/CLOZAPINE
- ANTI-RETROVIRALS; HYDROXYUREA/BETIBEGLOGENE AUTOTEMCEL
- PROTEASE INHIBITORS; COBICISTAT/TACROLIMUS
- SLT PROTEASE INHIBITORS;COBICISTAT/VONOPRAZAN-CLARITHROMYCIN
- STRONG CYP3A4 INHIBITORS/MITAPIVAT
- STR 3A4 INHIB PROL QT/TOLTERODINE (>1 MG IR OR >2 MG ER)
- STRONG CYP3A4 INHIBITORS/RIVOCERANIB
- STRONG CYP3A4 INHIBITORS/UPADACITINIB (>=30 MG)
- STRONG CYP3A4 INHIBITORS/RUPATADINE
- SELECT CYP3A4 INHIBITORS THAT PROLONG QT/TRAZODONE
- STRONG & MODERATE 3A4 INHIB THAT PROLONG QT/ENCORAFENIB
- STRONG CYP3A4 INHIBITORS/SURUFATINIB
- STRONG CYP3A4 INHIBITORS/AVACOPAN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/RIBOCICLIB
- STRONG CYP3A4 INHIBITORS/ATOGEPANT
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/MOBOCERTINIB
- STRONG 3A4 INHIBITORS THAT PROLONG QT/BEDAQUILINE;DELAMANID
- STRONG & MODERATE 3A4 INHIBITOR THAT PROLONG QT/FEXINIDAZOLE
- STRONG CYP3A4 INHIB THAT PROLONG QT/ARTEMETHER;LUMEFANTRINE
- OATP1B1-3 INHIBITORS/BRINCIDOFOVIR
- STRONG AND MODERATE CYP3A4 INHIBITORS/INFIGRATINIB
- SELECTED PROTEASE INHIBITORS/FLECAINIDE; PROPAFENONE
- STRONG CYP3A4 INHIBIT THAT PROLONG QT/PIMAVANSERIN (<=10 MG)
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/GLASDEGIB
- P-GLYCOPROTEIN (P-GP) INHIBITORS/RELUGOLIX
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/TOREMIFENE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/SUNITINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/PAZOPANIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/NILOTINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/LAPATINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/DASATINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/CRIZOTINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/CERITINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/BOSUTINIB
- STRONG CYP3A4 INHIBITORS/VINFLUNINE
- STRONG CYP3A4 INHIBITORS/VINCRISTINE
- STRONG CYP3A4 INHIBITORS/VINBLASTINE
- STRONG CYP3A4 INHIBITORS/TOFACITINIB
- STRONG CYP3A4 INHIBITORS/SONIDEGIB
- STRONG CYP3A4 INHIBITORS/RUXOLITINIB
- STRONG CYP3A4 INHIBITORS/PONATINIB
- STRONG CYP3A4 INHIBITORS/PALBOCICLIB
- STRONG CYP3A4 INHIBITORS/PACLITAXEL
- STRONG CYP3A4 INHIBITORS/OLAPARIB
- STRONG CYP3A4 INHIBITORS/IXABEPILONE
- STRONG CYP3A4 INHIBITORS/IDELALISIB
- STRONG CYP3A4 INHIBITORS/ERLOTINIB
- STRONG CYP3A4 INHIBITORS/DOXORUBICIN
- STRONG CYP3A4 INHIBITORS/DOCETAXEL
- STRONG CYP3A4 INHIBITORS/DABRAFENIB
- STRONG CYP3A4 INHIBITORS/COBIMETINIB
- STRONG CYP3A4 INHIBITORS/CABOZANTINIB
- STRONG CYP3A4 INHIBITORS/CABAZITAXEL
- STRONG CYP3A4 INHIBITORS/AXITINIB
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/SUVOREXANT
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/IVOSIDENIB
- DUAL STRONG CYP3A4 AND P-GP INHIBITORS/PRALSETINIB
- STRONG CYP3A4 INHIBITORS/PLITIDEPSIN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/VEMURAFENIB
- STRONG CYP3A4 INHIBITORS/LURBINECTEDIN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/QUETIAPINE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/SELPERCATINIB
- UGT1A1 INDUCERS/SACITUZUMAB GOVITECAN
- STRONG AND MODERATE CYP3A4 INHIBITORS/PEMIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/SELUMETINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/OSILODROSTAT
- STRONG CYP3A4 INHIBITORS/RIMEGEPANT
- STRONG CYP3A4 INHIBITORS/NIMODIPINE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/ROMIDEPSIN
- STRONG CYP3A4 INHIBITORS/TAZEMETOSTAT
- STRONG CYP3A4 INHIBITORS/AVAPRITINIB
- SELECTED CYP3A4 INHIBITORS/SALMETEROL COMBINATIONS
- STRONG AND MODERATE CYP3A4 INHIBITORS/LEMBOREXANT
- P-GLYCOPROTEIN (P-GP) OR UGT INDUCERS/LETERMOVIR
- STRONG CYP3A4 INHIBITORS/ELEXACAFTOR-TEZACAFTOR-IVACAFTOR
- STRONG CYP3A4 INHIBITORS/NALDEMEDINE
- STRONG CYP3A4 INHIBITORS/ISTRADEFYLLINE
- STRONG CYP3A4 INHIBITORS/FEDRATINIB
- STRONG CYP3A4 INHIBITORS/ENTRECTINIB
- STRONG CYP3A4 INHIBITORS/PEXIDARTINIB (200 MG)
- SELECTED PROTEASE INHIBITORS; COBICISTAT/CLOPIDOGREL
- SELECTED MODERATE CYP2C9 INDUCERS/SIPONIMOD
- STRONG CYP3A4 INHIBITORS/LAROTRECTINIB
- STRONG CYP3A4 INHIBITORS/LORLATINIB
- STRONG CYP3A4 INHIBITORS/DUVELISIB
- STRONG CYP3A4 INHIBITORS/ELAGOLIX
- STRONG CYP3A4 INHIBITORS/ARIPIPRAZOLE LAUROXIL SUBMICRONIZED
- SELECTED PROTEASE INHIBITORS/SODIUM FUSIDATE
- STRONG AND MODERATE CYP3A4 INHIBITORS/TEZACAFTOR-IVACAFTOR
- SELECTED INHIBITORS OF BCRP/CLADRIBINE
- LOPINAVIR-RITONAVIR/OMBITASVIR-PARITAPREVIR
- SELECTED STRONG CYP3A4 INHIBITOR;PROTEASE INHIB/DISOPYRAMIDE
- STRONG CYP3A4 INHIBITORS/IBRUTINIB
- STRONG CYP3A4 INHIBITORS/ACALABRUTINIB
- STRONG CYP3A4 INHIBITORS/ABEMACICLIB
- STRONG CYP3A4 INHIBITORS/COPANLISIB
- DARUNAVIR; LOPINAVIR; RITONAVIR/GLECAPREVIR-PIBRENTASVIR
- SELECTED OATP INHIBITORS/VOXILAPREVIR
- STRONG CYP3A4 INHIBITORS/BRIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/DEFLAZACORT
- SELECTED ANTIRETROVIRALS/ORLISTAT
- STRONG CYP3A4 INHIBITORS/VENETOCLAX
- STRONG CYP3A4 INHIBITORS/TRABECTEDIN
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/CARIPRAZINE
- OATP1B1 INHIBITORS/ELUXADOLINE
- SLT STRONG CYP3A4 INHIBITOR & SUBSTRATE/LUMACAFTOR-IVACAFTOR
- RITONAVIR/ISAVUCONAZONIUM
- STRONG CYP3A4 INHIBITORS/TRASTUZUMAB EMTANSINE
- STRONG 3A4 INHIBITORS/ESZOPICLONE > 2 MG; ZOPICLONE > 5 MG
- STRONG & MODERATE CYP3A4 INHIBITORS/ELIGLUSTAT
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/VORAPAXAR
- STRONG & MODERATE CYP3A4 INHIBITORS/GUANFACINE
- STRONG OR MODERATE CYP3A4 INHIBITORS/SIMEPREVIR
- STRONG CYP3A4 INHIBITORS/MACITENTAN
- DUAL STRONG CYP3A4 INHIBITOR & P-GP INHIBITORS/RIOCIGUAT
- UGT INDUCERS/CANAGLIFLOZIN
- STRONG CYP3A4 INHIBITORS/REGORAFENIB
- STRONG CYP3A4 INHIBITORS; AMPRENAVIR;ATAZANAVIR/MIFEPRISTONE
- STRONG AND MODERATE CYP3A4 INHIBITORS/IVACAFTOR
- SELECTED PROTEASE INHIBITORS/TELAPREVIR
- SELECTED PROTEASE INHIBITORS/QUININE
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/ALISKIREN
- COBICISTAT; PROTEASE INHIBITORS/SALMETEROL
- STRONG UGT INDUCERS/DEFERASIROX
- FOSAMPRENAVIR; RITONAVIR/ULIPRISTAL
- PROTEASE INHIBITORS/BOSENTAN
- STRONG CYP3A4 INHIBITORS; DARUNAVIR/EVEROLIMUS
- SLT PROTEASE INHIBITORS/BARBITURATES;PHENOBARBITAL;PHENYTOIN
- P-GLYCOPROTEIN (P-GP) INHIBITORS/TOPOTECAN
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/DABIGATRAN
- SELECTED PROTEASE INHIBITORS/MARAVIROC
- LOPINAVIR; SAQUINAVIR; OMBITAS-PARITAP-RITONAVIR/DARUNAVIR
- PROTEASE INH;COBICISTAT/SLT IMMUNOSUPPRESSANTS;TEMSIROLIMUS
- STRONG CYP3A4 INHIBITORS/COLCHICINE
- SELECTED CYP3A4 INHIBITORS/SELECTED OPIOIDS
- SELECTED CYP3A4 INHIBITORS/SELECTED STEROIDS
- ATAZANAVIR; COBICISTAT; RITONAVIR/VORICONAZOLE
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SELECTED PROTEASE INHIBITORS/DIDANOSINE
- LOPINAVIR/EFAVIRENZ; NEVIRAPINE
- ATAZANAVIR; RITONAVIR/POSACONAZOLE
- LOPINAVIR/POSSIBLE QT PROLONGING AGENTS
- COBICISTAT; RITONAVIR/TENOFOVIR ALAFENAMIDE (> 10 MG)
- SELECTED PROTEASE INHIBITORS/NIRMATRELVIR-RITONAVIR
- SELECTED PROTEASE INHIBITORS; COBICISTAT/OXCARBAZEPINE
- POSSIBLE QT PROLONGING AGENTS/DEXMEDETOMIDINE SUBLINGUAL
- STRONG CYP3A4 INHIBITORS/VAMOROLONE
- STRONG AND MODERATE 3A4 INHIBITORS THAT PROLONG QT/ETRASIMOD
- OATP1B1-3 INHIBITORS/MOMELOTINIB
- SLT STRONG CYP3A4 INHIBIT/AMLODIPINE; LEVAMLODIPINE
- STRONG CYP3A4 INHIBITORS/ZURANOLONE
- STR CYP3A4 INHIB;ATAZAN;DARUNAV/SLT LONG-ACTING ARIPIPRAZOLE
- STRONG CYP3A4 INHIBITORS/BORTEZOMIB
- SELECT PROTEASE INHIBITORS; COBICISTAT/TADALAFIL (PAH)
- STRONG CYP3A4 INHIBITORS/VALBENAZINE (=< 40 MG)
- QT PROLONGING AGENTS/TUCIDINOSTAT
- MODERATE CYP2B6 INDUCERS/BUPROPION COMBINATIONS
- STRONG CYP3A4 INHIB; PROTEASE INHIB/LUMATEPERONE (<=10.5 MG)
- RITONAVIR/CANNABIDIOL
- SELECTED CYP3A4 INHIBITORS/MOMETASONE
- QT PROLONGING AGENTS/TRICLABENDAZOLE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/GILTERITINIB
- STR 3A4 INHIBITORS THAT PROLONG QT/PANOBINOSTAT (<= 10 MG)
- STR 3A4 INHIB THAT PROL QT/TOLTERODINE (<=1 MG OR <=2 MG ER)
- STRONG CYP3A4 INHIBITORS/UPADACITINIB (<30 MG)
- OATP1B1-3 INHIBITORS/ATOGEPANT
- SELECTED POSSIBLE QT PROLONGING AGENTS/INTRAVENOUS LEFAMULIN
- QT PROLONGING AGENTS/OZANIMOD
- QT PROLONGING AGENTS/PONESIMOD
- QT PROLONGING AGENTS/SIPONIMOD
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/MIDOSTAURIN
- STRONG CYP3A4 INHIBITORS/IBREXAFUNGERP
- SELECTED CYP1A2 INDUCERS/OLANZAPINE-SAMIDORPHAN
- QT PROLONGING AGENTS/GALANTAMINE
- STRONG CYP3A4 INHIBITORS/REPAGLINIDE
- PROTEASE INHIBITORS/SELECTED BENZODIAZEPINES
- POSSIBLE QT PROLONGING AGENTS/LEVOMEPROMAZINE
- STRONG OR MODERATE CYP2D6 OR CYP3A4 INHIBITORS/OLICERIDINE
- STRONG CYP3A4 INHIBITORS/FOSTAMATINIB
- STRONG UGT INDUCERS; NEVIRAPINE/ARTESUNATE
- POSSIBLE QT PROLONGING AGENTS/OXALIPLATIN
- QT PROLONGING AGENTS/AMISULPRIDE
- STRONG CYP3A4 INHIBITORS/CANNABIDIOL-TETRAHYDROCANNABINOL
- SELECTED STRONG CYP3A4 INHIBITORS;PROTEASE INHIB/MEFLOQUINE
- STRONG CYP3A4 INHIBITORS/ZANUBRUTINIB
- DUAL P-GP AND STRONG CYP3A4 INHIBITORS/DAROLUTAMIDE
- SELECTED STRONG CYP3A4 INHIBITORS;PROTEASE INHIB/ILOPERIDONE
- SELECTED PROTEASE INHIBITORS; COBICISTAT/LIDOCAINE
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/BREXPIPRAZOLE
- LAPATINIB; RITONAVIR/EDOXABAN (<= 30 MG)
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/BETRIXABAN
- RITONAVIR/THYROID PREPARATIONS
- SELECTED CYP1A2 INDUCERS/OLANZAPINE
- SELECTED CYP3A4 INHIBITORS/BROMOCRIPTINE; CABERGOLINE
- SELECTED CYP3A4 INHIBITORS/FELODIPINE
- LAPATINIB; RITONAVIR/EDOXABAN (> 30 MG)
- LOPINAVIR; NELFINAVIR; NEVIRAPINE; RITONAVIR/WARFARIN DERIVS
- P-GP AND SELECTED CYP3A4 INHIBITORS/NINTEDANIB
- STRONG 3A4 INHIB/LEVOMILNACIPRAN(<=80MG);VILAZODONE(<=20MG)
- P-GLYCOPROTEIN (P-GP) INHIBITORS/AFATINIB
- QT PROLONGING AGENTS/FINGOLIMOD
- SELECTED PROTEASE INHIBITORS/ATORVASTATIN (<= 20 MG)
- BOCEPREVIR; RITONAVIR; TELAPREVIR/DIGOXIN
- MODERATE CYP2B6 INDUCERS/BUPROPION
- POSSIBLE QT PROLONGING AGENTS/GADOFOSVESET
- RITONAVIR/LEVOMETHADONE; METHADONE
- LOPINAVIR; RITONAVIR/LAMOTRIGINE
- SLT PROTEASE INHIB;COBICISTAT/SILDENAFIL (ED);TADALAFIL (ED)
- STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/SAXAGLIPTIN(<=2.5 MG)
- SLT STRONG CYP3A4 INHIBIT/SELECTED CALCIUM CHANNEL BLOCKERS
- ATAZANAVIR; LOPINAVIR; SIMEPREVIR/ROSUVASTATIN (<= 10 MG)
- SELECTED WEAK CYP2D6 INHIBITORS/TAMOXIFEN
- CYP3A4; CYP2C8; P-GLYCOPROTEIN (P-GP) INHIBITORS/LOPERAMIDE
- STRONG CYP3A4 INHIBITORS/BUSPIRONE
- LOPINAVIR/SELECTED PROTEASE INHIBITORS
- QT PROLONGING AGENTS/NORFLOXACIN
- STRONG CYP3A4 INHIBITORS/ESZOPICLONE; ZOPICLONE; ZOLPIDEM
- SELECTED CYP3A4 INHIBITORS/ITRACONAZOLE; KETOCONAZOLE
- STRONG CYP3A4 INHIBITORS/CINACALCET
- SELECTED PROTEASE INHIBITORS/SELECTED ANTIARRHYTHMICS
- SELECTED PROTEASE INHIBITORS/VARDENAFIL (<= 2.5 MG)
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/ARIPIPRAZOLE
- SELECTED PROTEASE INHIBITORS; COBICISTAT/CLARITHROMYCIN
- STRONG CYP3A4 INHIBITORS/SLT LOW STRENGTH ANTIMUSCARINICS
- SLT STRONG & MODERATE CYP3A4 INHIBITORS/CILOSTAZOL (<=50MG)
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.